Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Dr. Daniel TillettCEO, MD & Director | 400,00k | 357,96k | Derivative Exercise and Retained Stock | 0,89 | 20,27M | 2,01% |
| 2026-05-26 | Dr. Daniel TillettCEO, MD & Director | 400,00k | 358,09k | Derivative Exercise and Retained Stock | 0,90 | 19,87M | 2,05% |
| 2026-05-21 | Dr. Daniel TillettCEO, MD & Director | 248,34k | 221,24k | Derivative Exercise and Retained Stock | 0,89 | 19,47M | 1,29% |
| 2026-05-14 | Dr. Daniel TillettCEO, MD & Director | 200,00k | 180,58k | Derivative Exercise and Retained Stock | 0,90 | 19,22M | 1,05% |
| 2026-05-07 | Dr. Daniel TillettCEO, MD & Director | 200,00k | 181,20k | Derivative Exercise and Retained Stock | 0,91 | 19,02M | 1,06% |
| 2026-04-02 | Dr. Daniel TillettCEO, MD & Director | 200,00k | 172,67k | Derivative Exercise and Retained Stock | 0,86 | 18,82M | 1,07% |
| 2026-02-19 | Dr. Daniel TillettCEO, MD & Director | 100,00k | 88,20k | Derivative Exercise and Retained Stock | 0,88 | 18,62M | 0,54% |
| 2026-02-11 | Dr. Daniel TillettCEO, MD & Director | 62,63k | 63,76k | Acquisto | 1,02 | 18,52M | 0,34% |
| 2026-02-11 | Dr. Daniel TillettCEO, MD & Director | -14,00k | 14,25k | Vendita | 1,02 | 18,52M | -0,08% |
| 2026-01-22 | Dr. Daniel TillettCEO, MD & Director | 400,00k | 341,74k | Derivative Exercise and Retained Stock | 0,85 | 18,47M | 2,21% |
| 2025-12-12 | Dr. Daniel TillettCEO, MD & Director | 300,00k | 248,34k | Derivative Exercise and Retained Stock | 0,83 | 18,07M | 1,69% |
| 2025-12-12 | Dr. Daniel TillettCEO, MD & Director | 12,22k | 20,88k | Acquisto | 1,71 | 18,07M | 0,07% |
| 2025-11-26 | Dr. Daniel TillettCEO, MD & Director | 22,00k | 38,27k | Acquisto | 1,74 | 17,76M | 0,12% |
| 2025-11-26 | Dr. Peter Michael SmithExecutive Chairman | 9,43k | 16,31k | Acquisto | 1,73 | 9,43k | - |
| 2025-11-25 | Dr. Daniel TillettCEO, MD & Director | 432,68k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-11-25 | Dr. Daniel TillettCEO, MD & Director | -2,00M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-11-25 | Dr. Peter Michael SmithExecutive Chairman | 357,16k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
